Breaking News
Sort by:
Date
Top Post
SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy
SNIPR Biome, the company pioneering CRISPR microbial gene therapy, has announced positive interim clinical results […]
eTheRNA Immunotherapies Opens Office in Hong Kong to Support and Build on its Growing Activities in China and Broader Asia-Pacific
eTheRNA immunotherapies NV (‘eTheRNA’ or the ‘Company’), a clinical-stage company developing mRNA-based immunotherapies for the […]
eTheRNA and VUB to Engineer Next Generation mRNA Therapeutics with TetraMix ®
eTheRNA immunotherapies NV (‘eTheRNA’, Niel, Belgium), a clinical-stage company developing mRNA-based immunotherapies for the treatment of […]
- RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings Read more
- Visgenx Appoints William Pedranti as Chief Executive Officer Read more
- Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia Read more
- The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson’s Disease Read more
- ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities Read more